Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status
- Status
- COMPLETED
- Phase
- N/A
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy
- Status
- UNKNOWN
- Phase
- NA
PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).
- Status
- RECRUITING
- Phase
- NA
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Investigate LYL845 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study
- Status
- COMPLETED
- Phase
- NA
Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations
- Status
- WITHDRAWN
- Phase
- PHASE2
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
- Status
- RECRUITING
- Phase
- PHASE1
H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2